Ashwin Balagopal, MD

• Chair, ACTG 5335s
• Investigator ACTG 5329 and ACTG 5334s
• Investigator, Hepatitis Transformative Science Group (Feb 2016)

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...

IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...

Johns Hopkins University Baltimore-India Clinical Trials Unit